Antiviral treatments are becoming increasingly available for human viral diseases (HIV, HBV, HCV, influenza). As most of these viruses exist within patients as genetic variants, some of them might have mutations that confer resistance to the activity of the drugs. The use of viral genetic sequences to predict failure to antiviral treatment has made publicly available thousands of sequences. This is an invaluable source for many studies.


Read More: Drug resistance